Supplementation with Tex261 provides a possible preventive treatment for hypoxic pulmonary artery hypertension

• Main Authors: Shaokun Chen (Author), Xiaozhen Wei (Author), Xu Zhang (Author), Mengge Yao (Author), Zhihuang Qiu (Author), Liangwan Chen (Author), Li Zhang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: Pulmonary artery hypertension (PAH) is a serious disease for which there is no effective treatment. Its pathogenesis is complex and has not yet been clarified. Tex261 is a protein-coding gene whose functional enrichment nodes include the transporter activity of COP II. However, the role...